Identifier
Created
Classification
Origin
09BEIJING1816
2009-07-01 11:47:00
UNCLASSIFIED//FOR OFFICIAL USE ONLY
Embassy Beijing
Cable title:
H1N1 INFLUENZA OUTBREAK - CHINA SITREP # 22
how-toVZCZCXRO3552 RR RUEHCN RUEHDT RUEHGH RUEHPB RUEHVC DE RUEHBJ #1816 1821147 ZNR UUUUU ZZH R 011147Z JUL 09 FM AMEMBASSY BEIJING TO RUEHC/SECSTATE WASHDC 4923 INFO RUEHOO/CHINA POSTS COLLECTIVE RUEHBY/AMEMBASSY CANBERRA 9712 RUEHDN/AMCONSUL SYDNEY 0593 RUEAUSA/DEPT OF HHS WASHINGTON DC RUEHRC/DEPT OF AGRICULTURE WASHDC RUCPDOC/DEPT OF COMMERCE WASHDC RUEATRS/DEPT OF TREASURY WASHINGTON DC RHMFIUU/DEPT OF HOMELAND SECURITY WASHINGTON DC RUEKJCS/SECDEF WASHDC//USDP/ISA/AP// RHEHNSC/NSC WASHDC RUCNARF/ASEAN REGIONAL FORUM COLLECTIVE RUEHPH/CDC ATLANTA GA RUEAIIA/CIA WASHDC RHEFDIA/DIA WASHINGTON DC RHMFISS/CJCS WASHINGTON DC//J2/J3/J5// RHMFIUU/CDR USPACOM HONOLULU HI//J00/J2/J3/J5//
UNCLAS BEIJING 001816
HHS FOR OGHA
CDC ATLANTA FOR CCID, AND PASS TO FLU COX AND MOUNTS AND
COGH BLOUNT AND KELLEY
SENSITIVE
SIPDIS
E.O. 12958: N/A
TAGS: KFLU AEMR ASEC CASC KFLO TBIO KSAF KPAO PREL PINR
AMGT, MG, EAGR, HHS, CH
SUBJECT: H1N1 INFLUENZA OUTBREAK - CHINA SITREP # 22
REF: A) BEIJING 1705 B) BEIJING 1664 C) BEIJING 1636
D) BEIJING 1596 E) BEIJING 1548
867 CASES OF 2009 A/H1N1 CONFIRMED
-------------------- -------------
UNCLAS BEIJING 001816
HHS FOR OGHA
CDC ATLANTA FOR CCID, AND PASS TO FLU COX AND MOUNTS AND
COGH BLOUNT AND KELLEY
SENSITIVE
SIPDIS
E.O. 12958: N/A
TAGS: KFLU AEMR ASEC CASC KFLO TBIO KSAF KPAO PREL PINR
AMGT, MG, EAGR, HHS, CH
SUBJECT: H1N1 INFLUENZA OUTBREAK - CHINA SITREP # 22
REF: A) BEIJING 1705 B) BEIJING 1664 C) BEIJING 1636
D) BEIJING 1596 E) BEIJING 1548
867 CASES OF 2009 A/H1N1 CONFIRMED
-------------- --------------
1. (U) As of COB July 1, China's Ministry of Health (MOH) has
officially communicated information about 867 confirmed cases of
infection by the novel 2009 influenza A/H1N1. Confirmed cases have
been detected in 19 provinces and the municipalities of Beijing,
Chongqing, Shanghai and Tianjin. Of the 867 confirmed cases, MOH
reported that as of July 1, 523 infected patients had recovered and
been released from treatment. 341 infected patients are being
treated in isolation at local designated hospitals and three others
are currently being treated in isolation at home.
CHINA EASES H1H1 CONTROL MEASURES
-------------- --------------
2. (SBU) According to press reports over the last week, the Chinese
government has adjusted its quarantine and control measures and is
now allowing some patients infected with the A/H1N1 virus to be
treated in isolation at home, instead of being moved to or remaining
in a designated hospital. Since June 26, MOH has reported a total
of 14 confirmed A/H1N1 cases receiving treatment at home.
Previously, home quarantine had been reported only in cases of
medical observation of close contacts of confirmed cases.
CHINA PRODUCES FIRST BATCH OF A/H1N1 ANTIVIRAL DRUG
-------------- --------------
3. (SBU) Local press announced on June 26 that Shanghai
Pharmaceutical Group Co. Ltd (Shanghai Pharm) had produced China's
first batch of an antiviral drug to treat patients infected by the
A/H1N1 influenza virus. The antiviral drug, Oseltamivir Phosphate
Capsules, is the Chinese version of "Tamiflu" by Swiss drug maker
Roche Holding. Shanghai Pharm reportedly is one of only two Chinese
companies authorized by Roche to produce the Tamiflu-like drug.
GOLDBERG
HHS FOR OGHA
CDC ATLANTA FOR CCID, AND PASS TO FLU COX AND MOUNTS AND
COGH BLOUNT AND KELLEY
SENSITIVE
SIPDIS
E.O. 12958: N/A
TAGS: KFLU AEMR ASEC CASC KFLO TBIO KSAF KPAO PREL PINR
AMGT, MG, EAGR, HHS, CH
SUBJECT: H1N1 INFLUENZA OUTBREAK - CHINA SITREP # 22
REF: A) BEIJING 1705 B) BEIJING 1664 C) BEIJING 1636
D) BEIJING 1596 E) BEIJING 1548
867 CASES OF 2009 A/H1N1 CONFIRMED
-------------- --------------
1. (U) As of COB July 1, China's Ministry of Health (MOH) has
officially communicated information about 867 confirmed cases of
infection by the novel 2009 influenza A/H1N1. Confirmed cases have
been detected in 19 provinces and the municipalities of Beijing,
Chongqing, Shanghai and Tianjin. Of the 867 confirmed cases, MOH
reported that as of July 1, 523 infected patients had recovered and
been released from treatment. 341 infected patients are being
treated in isolation at local designated hospitals and three others
are currently being treated in isolation at home.
CHINA EASES H1H1 CONTROL MEASURES
-------------- --------------
2. (SBU) According to press reports over the last week, the Chinese
government has adjusted its quarantine and control measures and is
now allowing some patients infected with the A/H1N1 virus to be
treated in isolation at home, instead of being moved to or remaining
in a designated hospital. Since June 26, MOH has reported a total
of 14 confirmed A/H1N1 cases receiving treatment at home.
Previously, home quarantine had been reported only in cases of
medical observation of close contacts of confirmed cases.
CHINA PRODUCES FIRST BATCH OF A/H1N1 ANTIVIRAL DRUG
-------------- --------------
3. (SBU) Local press announced on June 26 that Shanghai
Pharmaceutical Group Co. Ltd (Shanghai Pharm) had produced China's
first batch of an antiviral drug to treat patients infected by the
A/H1N1 influenza virus. The antiviral drug, Oseltamivir Phosphate
Capsules, is the Chinese version of "Tamiflu" by Swiss drug maker
Roche Holding. Shanghai Pharm reportedly is one of only two Chinese
companies authorized by Roche to produce the Tamiflu-like drug.
GOLDBERG